Area of research
Genetics · Hematology
Research interest
Research interests include Iron Metabolism and Disorders, Hemoglobinopathies and Related Disorders, Folate and B Vitamins Research, and Chronic Lymphocytic Leukemia Research.
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies